SAMALIZUMAB
UNII 64EUX713G6

Substance Identification & Data

This profile provides standardized clinical and technical data for Samalizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 64EUX713G6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1073059-33-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

64EUX713G6

CAS Registry Number

1073059-33-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SAMALIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C77891

National Cancer Institute reference terminology for clinical and research data.

INN ID

9307

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

WW-105

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Samalizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SAMALIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN, ANTI-(CD200 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL ALXN6000 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL ALXN6000 .KAPPA.-CHAIN, DIMER

SAMALIZUMAB [INN]

SAMALIZUMAB [USAN]

SAMALIZUMAB [WHO-DD]